"World's Most Complete Market Research Reports Repository"

Global Head and Neck Cancer Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • Category : Healthcare & Pharma
  • |
  • ID : 675285
  • |
  • Publishe Date : 6-Nov-18
  • |
  • No of Pages: 120
  • |
  • Publisher : Global Info Research





Scope of the Report:

The global Head and Neck Cancer market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Head and Neck Cancer.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Head and Neck Cancer market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Head and Neck Cancer market by product type and applications/end industries.



Market Segment by Companies, this report covers

Sanofi

Pfizer

Eli Lilly and Company

AstraZeneca

Teva Pharmaceuticals

F. Hoffmann-La Roche

Fresenius Kabi

Merck

Bayer AG

Galera



Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)



Market Segment by Type, covers

EGFR Inhibitors

Mitotic Inhibitors

Anti-PD-1 Monoclonal Antibodies

Others



Market Segment by Applications, can be divided into

Hospitals Pharmacies

Retail Pharmacies

E-commerce

Table of Contents



1 Head and Neck Cancer Market Overview

1.1 Product Overview and Scope of Head and Neck Cancer

1.2 Classification of Head and Neck Cancer by Types

1.2.1 Global Head and Neck Cancer Revenue Comparison by Types (2017-2023)

1.2.2 Global Head and Neck Cancer Revenue Market Share by Types in 2017

1.2.3 EGFR Inhibitors

1.2.4 Mitotic Inhibitors

1.2.5 Anti-PD-1 Monoclonal Antibodies

1.2.6 Others

1.3 Global Head and Neck Cancer Market by Application

1.3.1 Global Head and Neck Cancer Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospitals Pharmacies

1.3.3 Retail Pharmacies

1.3.4 E-commerce

1.4 Global Head and Neck Cancer Market by Regions

1.4.1 Global Head and Neck Cancer Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Head and Neck Cancer Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Head and Neck Cancer Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Head and Neck Cancer Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Head and Neck Cancer Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Head and Neck Cancer Status and Prospect (2013-2023)

1.5 Global Market Size of Head and Neck Cancer (2013-2023)

2 Manufacturers Profiles

2.1 Sanofi

2.1.1 Business Overview

2.1.2 Head and Neck Cancer Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Sanofi Head and Neck Cancer Revenue, Gross Margin and Market Share (2016-2017)

2.2 Pfizer

2.2.1 Business Overview

2.2.2 Head and Neck Cancer Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Pfizer Head and Neck Cancer Revenue, Gross Margin and Market Share (2016-2017)

2.3 Eli Lilly and Company

2.3.1 Business Overview

2.3.2 Head and Neck Cancer Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Eli Lilly and Company Head and Neck Cancer Revenue, Gross Margin and Market Share (2016-2017)

2.4 AstraZeneca

2.4.1 Business Overview

2.4.2 Head and Neck Cancer Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 AstraZeneca Head and Neck Cancer Revenue, Gross Margin and Market Share (2016-2017)

2.5 Teva Pharmaceuticals

2.5.1 Business Overview

2.5.2 Head and Neck Cancer Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Teva Pharmaceuticals Head and Neck Cancer Revenue, Gross Margin and Market Share (2016-2017)

2.6 F. Hoffmann-La Roche

2.6.1 Business Overview

2.6.2 Head and Neck Cancer Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 F. Hoffmann-La Roche Head and Neck Cancer Revenue, Gross Margin and Market Share (2016-2017)

2.7 Fresenius Kabi

2.7.1 Business Overview

2.7.2 Head and Neck Cancer Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Fresenius Kabi Head and Neck Cancer Revenue, Gross Margin and Market Share (2016-2017)

2.8 Merck

2.8.1 Business Overview

2.8.2 Head and Neck Cancer Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Merck Head and Neck Cancer Revenue, Gross Margin and Market Share (2016-2017)

2.9 Bayer AG

2.9.1 Business Overview

2.9.2 Head and Neck Cancer Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Bayer AG Head and Neck Cancer Revenue, Gross Margin and Market Share (2016-2017)

2.10 Galera

2.10.1 Business Overview

2.10.2 Head and Neck Cancer Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Galera Head and Neck Cancer Revenue, Gross Margin and Market Share (2016-2017)

3 Global Head and Neck Cancer Market Competition, by Players

3.1 Global Head and Neck Cancer Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Head and Neck Cancer Players Market Share

3.2.2 Top 10 Head and Neck Cancer Players Market Share

3.3 Market Competition Trend

4 Global Head and Neck Cancer Market Size by Regions

4.1 Global Head and Neck Cancer Revenue and Market Share by Regions

4.2 North America Head and Neck Cancer Revenue and Growth Rate (2013-2018)

4.3 Europe Head and Neck Cancer Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Head and Neck Cancer Revenue and Growth Rate (2013-2018)

4.5 South America Head and Neck Cancer Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Head and Neck Cancer Revenue and Growth Rate (2013-2018)

5 North America Head and Neck Cancer Revenue by Countries

5.1 North America Head and Neck Cancer Revenue by Countries (2013-2018)

5.2 USA Head and Neck Cancer Revenue and Growth Rate (2013-2018)

5.3 Canada Head and Neck Cancer Revenue and Growth Rate (2013-2018)

5.4 Mexico Head and Neck Cancer Revenue and Growth Rate (2013-2018)

6 Europe Head and Neck Cancer Revenue by Countries

6.1 Europe Head and Neck Cancer Revenue by Countries (2013-2018)

6.2 Germany Head and Neck Cancer Revenue and Growth Rate (2013-2018)

6.3 UK Head and Neck Cancer Revenue and Growth Rate (2013-2018)

6.4 France Head and Neck Cancer Revenue and Growth Rate (2013-2018)

6.5 Russia Head and Neck Cancer Revenue and Growth Rate (2013-2018)

6.6 Italy Head and Neck Cancer Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Head and Neck Cancer Revenue by Countries

7.1 Asia-Pacific Head and Neck Cancer Revenue by Countries (2013-2018)

7.2 China Head and Neck Cancer Revenue and Growth Rate (2013-2018)

7.3 Japan Head and Neck Cancer Revenue and Growth Rate (2013-2018)

7.4 Korea Head and Neck Cancer Revenue and Growth Rate (2013-2018)

7.5 India Head and Neck Cancer Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Head and Neck Cancer Revenue and Growth Rate (2013-2018)

8 South America Head and Neck Cancer Revenue by Countries

8.1 South America Head and Neck Cancer Revenue by Countries (2013-2018)

8.2 Brazil Head and Neck Cancer Revenue and Growth Rate (2013-2018)

8.3 Argentina Head and Neck Cancer Revenue and Growth Rate (2013-2018)

8.4 Colombia Head and Neck Cancer Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Head and Neck Cancer by Countries

9.1 Middle East and Africa Head and Neck Cancer Revenue by Countries (2013-2018)

9.2 Saudi Arabia Head and Neck Cancer Revenue and Growth Rate (2013-2018)

9.3 UAE Head and Neck Cancer Revenue and Growth Rate (2013-2018)

9.4 Egypt Head and Neck Cancer Revenue and Growth Rate (2013-2018)

9.5 Nigeria Head and Neck Cancer Revenue and Growth Rate (2013-2018)

9.6 South Africa Head and Neck Cancer Revenue and Growth Rate (2013-2018)

10 Global Head and Neck Cancer Market Segment by Type

10.1 Global Head and Neck Cancer Revenue and Market Share by Type (2013-2018)

10.2 Global Head and Neck Cancer Market Forecast by Type (2018-2023)

10.3 EGFR Inhibitors Revenue Growth Rate (2013-2023)

10.4 Mitotic Inhibitors Revenue Growth Rate (2013-2023)

10.5 Anti-PD-1 Monoclonal Antibodies Revenue Growth Rate (2013-2023)

10.6 Others Revenue Growth Rate (2013-2023)

11 Global Head and Neck Cancer Market Segment by Application

11.1 Global Head and Neck Cancer Revenue Market Share by Application (2013-2018)

11.2 Head and Neck Cancer Market Forecast by Application (2018-2023)

11.3 Hospitals Pharmacies Revenue Growth (2013-2018)

11.4 Retail Pharmacies Revenue Growth (2013-2018)

11.5 E-commerce Revenue Growth (2013-2018)

12 Global Head and Neck Cancer Market Size Forecast (2018-2023)

12.1 Global Head and Neck Cancer Market Size Forecast (2018-2023)

12.2 Global Head and Neck Cancer Market Forecast by Regions (2018-2023)

12.3 North America Head and Neck Cancer Revenue Market Forecast (2018-2023)

12.4 Europe Head and Neck Cancer Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Head and Neck Cancer Revenue Market Forecast (2018-2023)

12.6 South America Head and Neck Cancer Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Head and Neck Cancer Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures



Figure Head and Neck Cancer Picture

Table Product Specifications of Head and Neck Cancer

Table Global Head and Neck Cancer and Revenue (Million USD) Market Split by Product Type

Figure Global Head and Neck Cancer Revenue Market Share by Types in 2017

Figure EGFR Inhibitors Picture

Figure Mitotic Inhibitors Picture

Figure Anti-PD-1 Monoclonal Antibodies Picture

Figure Others Picture

Table Global Head and Neck Cancer Revenue (Million USD) by Application (2013-2023)

Figure Head and Neck Cancer Revenue Market Share by Applications in 2017

Figure Hospitals Pharmacies Picture

Figure Retail Pharmacies Picture

Figure E-commerce Picture

Table Global Market Head and Neck Cancer Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Head and Neck Cancer Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Head and Neck Cancer Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Head and Neck Cancer Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Head and Neck Cancer Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Head and Neck Cancer Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Head and Neck Cancer Revenue (Million USD) and Growth Rate (2013-2023)

Table Sanofi Basic Information, Manufacturing Base and Competitors

Table Sanofi Head and Neck Cancer Type and Applications

Table Sanofi Head and Neck Cancer Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Head and Neck Cancer Type and Applications

Table Pfizer Head and Neck Cancer Revenue, Gross Margin and Market Share (2016-2017)

Table Eli Lilly and Company Basic Information, Manufacturing Base and Competitors

Table Eli Lilly and Company Head and Neck Cancer Type and Applications

Table Eli Lilly and Company Head and Neck Cancer Revenue, Gross Margin and Market Share (2016-2017)

Table AstraZeneca Basic Information, Manufacturing Base and Competitors

Table AstraZeneca Head and Neck Cancer Type and Applications

Table AstraZeneca Head and Neck Cancer Revenue, Gross Margin and Market Share (2016-2017)

Table Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Teva Pharmaceuticals Head and Neck Cancer Type and Applications

Table Teva Pharmaceuticals Head and Neck Cancer Revenue, Gross Margin and Market Share (2016-2017)

Table F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors

Table F. Hoffmann-La Roche Head and Neck Cancer Type and Applications

Table F. Hoffmann-La Roche Head and Neck Cancer Revenue, Gross Margin and Market Share (2016-2017)

Table Fresenius Kabi Basic Information, Manufacturing Base and Competitors

Table Fresenius Kabi Head and Neck Cancer Type and Applications

Table Fresenius Kabi Head and Neck Cancer Revenue, Gross Margin and Market Share (2016-2017)

Table Merck Basic Information, Manufacturing Base and Competitors

Table Merck Head and Neck Cancer Type and Applications

Table Merck Head and Neck Cancer Revenue, Gross Margin and Market Share (2016-2017)

Table Bayer AG Basic Information, Manufacturing Base and Competitors

Table Bayer AG Head and Neck Cancer Type and Applications

Table Bayer AG Head and Neck Cancer Revenue, Gross Margin and Market Share (2016-2017)

Table Galera Basic Information, Manufacturing Base and Competitors

Table Galera Head and Neck Cancer Type and Applications

Table Galera Head and Neck Cancer Revenue, Gross Margin and Market Share (2016-2017)

Table Global Head and Neck Cancer Revenue (Million USD) by Players (2013-2018)

Table Global Head and Neck Cancer Revenue Share by Players (2013-2018)

Figure Global Head and Neck Cancer Revenue Share by Players in 2016

Figure Global Head and Neck Cancer Revenue Share by Players in 2017

Figure Global Top 5 Players Head and Neck Cancer Revenue Market Share in 2017

Figure Global Top 10 Players Head and Neck Cancer Revenue Market Share in 2017

Figure Global Head and Neck Cancer Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Head and Neck Cancer Revenue (Million USD) by Regions (2013-2018)

Table Global Head and Neck Cancer Revenue Market Share by Regions (2013-2018)

Figure Global Head and Neck Cancer Revenue Market Share by Regions (2013-2018)

Figure Global Head and Neck Cancer Revenue Market Share by Regions in 2017

Figure North America Head and Neck Cancer Revenue and Growth Rate (2013-2018)

Figure Europe Head and Neck Cancer Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Head and Neck Cancer Revenue and Growth Rate (2013-2018)

Figure South America Head and Neck Cancer Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Head and Neck Cancer Revenue and Growth Rate (2013-2018)

Table North America Head and Neck Cancer Revenue by Countries (2013-2018)

Table North America Head and Neck Cancer Revenue Market Share by Countries (2013-2018)

Figure North America Head and Neck Cancer Revenue Market Share by Countries (2013-2018)

Figure North America Head and Neck Cancer Revenue Market Share by Countries in 2017

Figure USA Head and Neck Cancer Revenue and Growth Rate (2013-2018)

Figure Canada Head and Neck Cancer Revenue and Growth Rate (2013-2018)

Figure Mexico Head and Neck Cancer Revenue and Growth Rate (2013-2018)

Table Europe Head and Neck Cancer Revenue (Million USD) by Countries (2013-2018)

Figure Europe Head and Neck Cancer Revenue Market Share by Countries (2013-2018)

Figure Europe Head and Neck Cancer Revenue Market Share by Countries in 2017

Figure Germany Head and Neck Cancer Revenue and Growth Rate (2013-2018)

Figure UK Head and Neck Cancer Revenue and Growth Rate (2013-2018)

Figure France Head and Neck Cancer Revenue and Growth Rate (2013-2018)

Figure Russia Head and Neck Cancer Revenue and Growth Rate (2013-2018)

Figure Italy Head and Neck Cancer Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Head and Neck Cancer Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Head and Neck Cancer Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Head and Neck Cancer Revenue Market Share by Countries in 2017

Figure China Head and Neck Cancer Revenue and Growth Rate (2013-2018)

Figure Japan Head and Neck Cancer Revenue and Growth Rate (2013-2018)

Figure Korea Head and Neck Cancer Revenue and Growth Rate (2013-2018)

Figure India Head and Neck Cancer Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Head and Neck Cancer Revenue and Growth Rate (2013-2018)

Table South America Head and Neck Cancer Revenue by Countries (2013-2018)

Table South America Head and Neck Cancer Revenue Market Share by Countries (2013-2018)

Figure South America Head and Neck Cancer Revenue Market Share by Countries (2013-2018)

Figure South America Head and Neck Cancer Revenue Market Share by Countries in 2017

Figure Brazil Head and Neck Cancer Revenue and Growth Rate (2013-2018)

Figure Argentina Head and Neck Cancer Revenue and Growth Rate (2013-2018)

Figure Colombia Head and Neck Cancer Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Head and Neck Cancer Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Head and Neck Cancer Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Head and Neck Cancer Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Head and Neck Cancer Revenue Market Share by Countries in 2017

Figure Saudi Arabia Head and Neck Cancer Revenue and Growth Rate (2013-2018)

Figure UAE Head and Neck Cancer Revenue and Growth Rate (2013-2018)

Figure Egypt Head and Neck Cancer Revenue and Growth Rate (2013-2018)

Figure Nigeria Head and Neck Cancer Revenue and Growth Rate (2013-2018)

Figure South Africa Head and Neck Cancer Revenue and Growth Rate (2013-2018)

Table Global Head and Neck Cancer Revenue (Million USD) by Type (2013-2018)

Table Global Head and Neck Cancer Revenue Share by Type (2013-2018)

Figure Global Head and Neck Cancer Revenue Share by Type (2013-2018)

Figure Global Head and Neck Cancer Revenue Share by Type in 2017

Table Global Head and Neck Cancer Revenue Forecast by Type (2018-2023)

Figure Global Head and Neck Cancer Market Share Forecast by Type (2018-2023)

Figure Global EGFR Inhibitors Revenue Growth Rate (2013-2018)

Figure Global Mitotic Inhibitors Revenue Growth Rate (2013-2018)

Figure Global Anti-PD-1 Monoclonal Antibodies Revenue Growth Rate (2013-2018)

Figure Global Others Revenue Growth Rate (2013-2018)

Table Global Head and Neck Cancer Revenue by Application (2013-2018)

Table Global Head and Neck Cancer Revenue Share by Application (2013-2018)

Figure Global Head and Neck Cancer Revenue Share by Application (2013-2018)

Figure Global Head and Neck Cancer Revenue Share by Application in 2017

Table Global Head and Neck Cancer Revenue Forecast by Application (2018-2023)

Figure Global Head and Neck Cancer Market Share Forecast by Application (2018-2023)

Figure Global Hospitals Pharmacies Revenue Growth Rate (2013-2018)

Figure Global Retail Pharmacies Revenue Growth Rate (2013-2018)

Figure Global E-commerce Revenue Growth Rate (2013-2018)

Figure Global Head and Neck Cancer Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Head and Neck Cancer Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Head and Neck Cancer Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Head and Neck Cancer Revenue Market Forecast (2018-2023)

Figure Europe Head and Neck Cancer Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Head and Neck Cancer Revenue Market Forecast (2018-2023)

Figure South America Head and Neck Cancer Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Head and Neck Cancer Revenue Market Forecast (2018-2023)

Choose License Type